NDC 0078-0811

Sandostatin LAR Depot

Octreotide Acetate

Sandostatin LAR Depot is a Kit in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is .

Product ID0078-0811_09c39d97-0b90-4a50-b3f7-ba58cc175186
NDC0078-0811
Product TypeHuman Prescription Drug
Proprietary NameSandostatin LAR Depot
Generic NameOctreotide Acetate
Dosage FormKit
Marketing Start Date2016-07-22
Marketing CategoryNDA / NDA
Application NumberNDA021008
Labeler NameNovartis Pharmaceuticals Corporation
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0078-0811-81

1 KIT in 1 KIT (0078-0811-81) * 6 mL in 1 VIAL (0078-0790-61) * 2 mL in 1 SYRINGE
Marketing Start Date2016-07-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0078-0811-81 [00078081181]

Sandostatin LAR Depot KIT
Marketing CategoryNDA
Application NumberNDA021008
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-07-22

Drug Details

OpenFDA Data

SPL SET ID:d0b7fe9e-7000-4b79-ba3b-291ce92c14f9
Manufacturer
RxNorm Concept Unique ID - RxCUI
  • 898601
  • 898603
  • 898605
  • 898607
  • 898589
  • 898591

    • NDC Crossover Matching brand name "Sandostatin LAR Depot" or generic name "Octreotide Acetate"

    NDCBrand NameGeneric Name
    0078-0647Sandostatin LAR Depotoctreotide acetate
    0078-0648Sandostatin LAR Depotoctreotide acetate
    0078-0811Sandostatin LAR Depotoctreotide acetate
    0078-0818Sandostatin LAR Depotoctreotide acetate
    0078-0825Sandostatin LAR Depotoctreotide acetate
    0641-6174Octreotide AcetateOctreotide Acetate
    0641-6175Octreotide AcetateOctreotide Acetate
    0078-0180Sandostatinoctreotide acetate
    0078-0181Sandostatinoctreotide acetate
    0078-0182Sandostatinoctreotide acetate
    0078-0183Sandostatinoctreotide acetate
    0078-0184Sandostatinoctreotide acetate
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.